-+ 0.00%
-+ 0.00%
-+ 0.00%

Medicus Pharma reports 80% ORR in Phase 2 SkinJect 200µg cohort at Day 57; FY2025 cash and cash equivalents fall to $9 million at year-end

Reuters·03/26/2026 11:32:09

Please log in to view news